News

If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE). The pharmaceutical giant isn't as risky an investment as it may appear to be. Its

So, you want to invest in AbbVie (NYSE: ABBV) because it's a promising dividend-paying stock, and you also want to receive $1,000 per year in dividend income from it. How many shares should you buy

Full-service dining restaurant chain specialist Darden Restaurants (NYSE:DRI) reported mixed fiscal 2025 third-quarter earnings on Thursday, March 20. Revenue of $3.16 billion rose 6.2% year over

Bank of America (NYSE: BAC) has become one of the world's largest financial services companies. While it survived and came out of the Great Recession as a bigger firm, it wasn't smooth sailing. Its

Here's our initial take on Accenture's (NYSE: ACN) fiscal 2025 second-quarter financial report.

In a quarter that for many was marred by customer hesitation to spend, Accenture continues to see

Mediterranean fast-casual restaurant chain Cava Group (NYSE: CAVA) is a rapidly growing business. It's often compared to Chipotle Mexican Grill, with investors seeing it as the next big growth stock

The price of many artificial intelligence (AI) stocks has dropped since the beginning of the year, creating a buying opportunity for investors looking to benefit from one of the largest tech trends

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons it is home to solid dividend stocks, including Pfizer (NYSE: PFE) and

Following Palantir Technologies' (NASDAQ: PLTR) recent customer event, Jefferies analyst Brent Hill maintained an underperform (sell) rating on the shares with a $60 price target, implying potential

Professional services and consulting specialist Accenture (NYSE:ACN) reported fiscal 2025 second-quarter results on Thursday, March 20, that topped analysts' consensus expectations. Revenue of

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020

In this podcast, Motley Fool analyst David Meier and host Dylan Lewis discuss:

It's no secret that a lot of investors have high hopes about the future of artificial intelligence. But how do genuine

One Wall Street analyst thinks investors can book some nice profits by investing in Norwegian Cruise Line (NYSE: NCLH) stock right now. That's because demand for booking cruise vacations looks to be

Coffee giant Starbucks (NASDAQ: SBUX) could use some Wall Street caffeine these days.

As of this writing on March 18, the stock is down 15% since the end of February. The broader market is also

They say a rising tide lifts all boats. Well, the reverse is true, too: A falling tide lowers all boats. As it is in the water, so it is in the stock market.

Case in point: As of this writing, the

Nvidia (NASDAQ: NVDA) has dominated the artificial intelligence (AI) computing hardware game for the entirety of the AI arms race, but there's one company aiming to change that: Broadcom (NASDAQ:

If you're behind in your saving and investing for retirement, you're not alone. According to the 2024 Retirement Confidence Survey, fully 47% of workers have less than $100,000 socked away, and 29%

It's been five years since the 2020 market crash, when news of a global pandemic sent investors into a panic. For investors brave enough to buy amid that crash, the gains for many stocks have been

Real estate investment trusts (REIT) are a favorite target of income-seeking investors, since the law requires them to distribute most of their earnings as dividends to maintain their tax-advantaged

McDonald's (NYSE: MCD) and Restaurant Brands International (NYSE: QSR) are two top restaurant stocks you can buy and hold for the long term. The former focuses on one massive brand while the latter

There's a new administration in Washington, D.C., and it has a short-term plan for the energy sector whose key goal is to quickly lower energy prices for consumers. But income-focused investors

Last year, Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech, attracted the market's attention thanks to excellent midstage clinical trial results. The company's shares soared in late February

Cryptocurrencies have been volatile lately.

That's the unpredictable backdrop to any serious analysis of cryptocurrencies in March 2025. The election drove many coins sky-high, as investors hoped